Navigation Links
Selecting high-risk patients for heart screening
Date:4/25/2010

Using routine data from electronic patient records to select individuals at high risk of developing heart disease, rather than screening all adults aged between 40 and 74 years of age, is just as effective at saving lives but will be cheaper to run, according to research published on bmj.com today.

Despite a significant decrease in heart disease in the last twenty years, heart problems remain the leading cause of ill health and death in the UK. Heart disease also costs the UK economy around 30 billion every year.

In an attempt to tackle this major health problem, the UK government is introducing a national vascular screening programme to identify individuals at high risk of developing heart disease. All adults between the ages of 40 to 74, free of diagnosed diabetes, heart disease and high blood pressure, will be invited to their surgery for a health check. This assessment will include blood tests, blood pressure monitoring and a heart disease review. Individuals will receive further treatment depending on the results of their tests.

The screening programme is expected to prevent 9,500 heart attacks and strokes every year and will cost around 250 million.

The authors, led by Dr Simon Griffin from the MRC Epidemiology Unit, investigated how the government screening programme would compare to systems where high risk patients would be pre-selected and invited for assessment and possible treatment.

Griffin, Chamnan and colleagues assessed data from participants in the UK EPIC-Norfolk study, a major European investigation into the causes of cancer and other chronic diseases. Almost 17,000 men and women between the ages of 40-74, who were free from heart disease and diabetes at the start of the study, took part in the research.

The researchers examined different screening strategies to determine which ones were most effective. These included inviting all 40-74 year olds for vascular screening (Department of Health recommendation), inviting 50-74 year olds for screening, inviting overweight men and women for screening, asking patients to complete a heart disease risk questionnaire (those with a high score would be invited for screening), and finally inviting patients whose data from their electronic patient records would flag them up as high risk.

The results show that the final strategy - using routine data to select high risk patients - is just as effective at the government screening programme at preventing new cases of heart disease and will save costs. A similar benefit could be achieved by inviting all 50 to 74 year olds for vascular screening (rather than starting at the age of 40).

In conclusion, the authors say that: "a universal screening programme for cardiovascular disease might prevent an important number of new cardiovascular events in a population, but it may be unrealistic to implement in increasingly resource constrained health systems policy makers have to decide on the balance between the number of people needed to screen or treat and the number of cases that can be prevented in the population."

In an accompanying editorial, Tom Marshall from the University of Birmingham, agrees that targeted screening programmes should be used. He says: "there are untreated patients at high risk of cardiovascular disease, most of whom can be identified from their electronic primary care records we should act on this information."


'/>"/>

Contact: Emma Dickinson
edickinson@bmjgroup.com
44-207-383-6529
BMJ-British Medical Journal
Source:Eurekalert

Related medicine news :

1. What to Look for When Selecting an Electronic Health Record for Your Community Oncology Practice - Free Educational Webinar
2. Surgical quality program is a strong tool for assessing outcomes for high-risk procedures
3. High-Risk Women May Often Avoid Using Tamoxifen
4. High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds
5. Mammograms May Boost Cancer Risk in High-Risk Women
6. Mammography may increase breast cancer risk in some high-risk women
7. Mammography May Increase Breast Cancer Risk in Some High-Risk Women
8. Many High-Risk Women Refuse Breast MRI
9. Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists
10. Monitoring of high-risk medications unchanged despite FDA warnings
11. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology: